Sequoia Genetics has received the European CE mark for its VariFind Neonatal assay for screening for cystic fibrosis and galactosemia in newborns. The assay runs on Life Technologies' Ion Torrent PGM and is approved for in vitro diagnostics in the European Economic Area.

The Russian molecular genetics company completed a clinical trial of its test in three European labs — the Institute of Molecular Pathology and Immunology of the University of Porto, Stab Vida in Portugal, and the Centre for Genomic Research at the University of Liverpool.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

In Science this week: the Human Silencing Hub protein complex, and more.

Heads of various research funding agencies discuss how to encourage scientific breakthroughs, ScienceInsider reports.

The Kansas City Star examines issues surrounding newborn genome sequencing.

Researchers say their Research Resource Identifier citation format is catching on, Nature News reports.